DrugPatentWatch Database Preview
Digoxin - Generic Drug Details
» See Plans and Pricing
What are the generic sources for digoxin and what is the scope of freedom to operate?
Digoxin
is the generic ingredient in five branded drugs marketed by Glaxosmithkline Llc, Hikma, Vistapharm, Abraxis Pharm, Hospira, Sandoz Inc, West-ward Pharms Int, Wyeth Ayerst, Covis Pharma Bv, Hikma Intl Pharms, Impax Labs, Mylan Pharms Inc, Stevens J, Sun Pharm Inds Inc, and Concordia, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.There are ten drug master file entries for digoxin. Thirty-one suppliers are listed for this compound.
Summary for digoxin
| US Patents: | 0 |
| Tradenames: | 5 |
| Applicants: | 15 |
| NDAs: | 17 |
| Drug Master File Entries: | 10 |
| Suppliers / Packagers: | 31 |
| Bulk Api Vendors: | 66 |
| Clinical Trials: | 176 |
| Patent Applications: | 8,917 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price trends for digoxin |
| Drug Sales Revenues: | Drug sales revenues for digoxin |
| DailyMed Link: | digoxin at DailyMed |
Recent Clinical Trials for digoxin
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Phase 2 |
| Maimonides Medical Center | Phase 2 |
| Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
Pharmacology for digoxin
| Drug Class | Cardiac Glycoside |
Medical Subject Heading (MeSH) Categories for digoxin
US Patents and Regulatory Information for digoxin
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz Inc | DIGOXIN | digoxin | INJECTABLE;INJECTION | 040481-001 | Aug 21, 2003 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Impax Labs | DIGOXIN | digoxin | TABLET;ORAL | 078556-001 | Jul 20, 2009 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Hikma Intl Pharms | DIGOXIN | digoxin | TABLET;ORAL | 077002-002 | Oct 30, 2007 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for digoxin
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Glaxosmithkline Llc | LANOXICAPS | digoxin | CAPSULE;ORAL | 018118-002 | Jul 26, 1982 | Start Trial | Start Trial |
| Glaxosmithkline Llc | LANOXICAPS | digoxin | CAPSULE;ORAL | 018118-004 | Sep 24, 1984 | Start Trial | Start Trial |
| Glaxosmithkline Llc | LANOXICAPS | digoxin | CAPSULE;ORAL | 018118-001 | Jul 26, 1982 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2020 - 2021
NCE-1 Patent Challenge Dates 2020 - 2021
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2020, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
